Global Cardiology Academy - Global Cardiology Academy

Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Popular

No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CE
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD; Katherine Tuttle, MD
0.25 credits
- Brendon Neuen, MBBS, PhD
- Katherine Tuttle, MD
0.25 credits
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart Matters
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD; Payal Kohli, MD, FACC
- Shelina Ramnarine, PhD
- Payal Kohli, MD, FACC
CME/CE In-Person Event
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
August 29, 2026
Munich
0.75 credits
CME/CE In-Person Event
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
Munich
0.75 credits
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart Matters
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
PiB PET Uncovers Hidden ATTR-CM
PiB PET Uncovers Hidden ATTR-CM
Heart Matters
PiB PET Uncovers Hidden ATTR-CM
Exploring Deeper Silencing in Transthyretin Amyloidosis
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstracts
Exploring Deeper Silencing in Transthyretin Amyloidosis
Ryan Quigley
- Ryan Quigley
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart Matters
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
- Valmiki Maharaj, MD

Programs

Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's Roundtable
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's Roundtable
Multi-Omics Brings New Clarity to the REHAB-PH Trial
How Symptoms Shape Caregiver Burden in ATTR-CM
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstracts
How Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
- Ryan Quigley
CME/CE In-Person Event
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
August 29, 2026
Munich
0.75 credits
Understanding Real-World Testing Patterns in ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD; Ronald Witteles, MD
- Steve Jackson, PharmD
- Ronald Witteles, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CM
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD; Valmiki Maharaj, MD
- Shelina Ramnarine, PhD
- Valmiki Maharaj, MD
Understanding the Mechanisms Behind Resistant Hypertension
Understanding the Mechanisms Behind Resistant Hypertension
Heart Matters
Understanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD; Jan Basile, MD
- Steve Jackson, PharmD
- Jan Basile, MD
- Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Understanding Residual Cardiovascular Risk in CKD and T2D
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes Discourse
Understanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
- John W. Ostrominski, MD, MPH

Clinical Practice

Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia Syndrome
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD; Nivedita Patni, MD
- Steve Jackson, PharmD
- Nivedita Patni, MD
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's Roundtable
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstracts
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
- Ryan Quigley
Closing Diagnostic Gaps in ATTR-CM
Closing Diagnostic Gaps in ATTR-CM
Heart Matters
Closing Diagnostic Gaps in ATTR-CM
Ronald Witteles, MD
- Ronald Witteles, MD
Recognizing and Managing Swelling in ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD; Kevin S. Shah, MD
- Steve Jackson, PharmD
- Kevin S. Shah, MD
Leadoff Hitter – Spotting High-Risk Players
Leadoff Hitter – Spotting High-Risk Players
MinuteCE®
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
0.75 program credits
- J.A. Randy Englert, MD, FACC
0.75 program credits
Swing for the Fences – LDL-C as the Power Hitter
Swing for the Fences – LDL-C as the Power Hitter
MinuteCE®
Swing for the Fences – LDL-C as the Power Hitter
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Extra Innings – Sustaining Victory Beyond the First Game
Extra Innings – Sustaining Victory Beyond the First Game
MinuteCE®
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits

CME

Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME/CE
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH; Koichiro Kinugawa, MD
0.25 credits
- Muthiah Vaduganathan, MD, MPH
- Koichiro Kinugawa, MD
- Michael Böhm, MD
0.25 credits
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Unblocking Clinical Inertia: The CMI Era in oHCM Care
CME/CE Broadcast Replay
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Iacopo Olivotto, MD; Elena Arbelo
0.75 credits
- Iacopo Olivotto, MD
- Elena Arbelo
- Silvia Aguiar
0.75 credits
Small Ball Wins Games – Combination Therapy for Goal Attainment
Small Ball Wins Games – Combination Therapy for Goal Attainment
MinuteCE®
Small Ball Wins Games – Combination Therapy for Goal Attainment
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Crossing Home Plate – Building a Winning Team Culture
Crossing Home Plate – Building a Winning Team Culture
MinuteCE®
Crossing Home Plate – Building a Winning Team Culture
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
MinuteCE®
ASCVD Playbook | Closing the Gaps, One Inning at a Time
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
- Joseph Rossano, MD
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
CME/CE
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Stephen J. Greene, MD, FACC, FHFSA; Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Stephen J. Greene, MD, FACC, FHFSA
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CE
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD; David Cherney, MD, PhD
0.50 credits
- Richard E. Pratley, MD
- David Cherney, MD, PhD
- prof. Hiddo Heerspink
0.50 credits

Medical News

Medical News
ACTN2 Variants in HCM Show Distinct Protein Effects
07/28/2026
Read more
Medical News
Heart Transplant Disparities Tied to Center-Level Decisions
07/28/2026
Read more
Medical News
Weight Loss Trial in Older Adults with Persistent Atrial Fibrillation
07/27/2026
Read more
Medical News
Food Supplementation After Heart Failure Hospitalization
07/27/2026
Read more
Medical News
Cardiac Rehabilitation Lowers Risk in Rheumatoid Arthritis with Hypertension
07/27/2026
Read more
Medical News
Commercial Cardiology Prices Varied Widely Across US Insurers
07/27/2026
Read more
Medical News
0/1-Hour vs 0/3-Hour Troponin Pathways in Suspected ACS
07/27/2026
Read more
Medical News
Trientine in Hypertrophic Cardiomyopathy Phase 2 Trial
07/20/2026
Read more